News | September 20, 2010

Transcatheter VAD Clinical Data Presented at TCT

September 20, 2010 – Transcatheter ventricular assist device (VAD) company Abiomed will highlight its devices at several events during the 2010 Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, Sept, 21-25, at the Washington Convention Center in Washington, D.C.

Abiomed is hosting a three-part breakfast series, featuring updates to the USpella registry, Impella case reviews and real-world applications of its Impella VADs. The update to the USpella registry, a U.S. multicenter observational registry of approximately 351 Impella 2.5 patients, will be presented by William O’Neill, M.D., University of Miami, at the Abiomed breakfast session at 7 a.m. Thursday, Sept. 23, and also presented later that day by Brijeshwar Maini, M.D., Pinnacle Health and Vascular Institute, during TCT “Session III: Optimizing Primary PCI for STEMI in the Cath Lab.”

Abiomed will also conduct daily booth demonstrations at booth 1403 and hands-on simulations of its heart recovery platforms. The company anticipates live cases utilizing Impella to be broadcast from the participating live case sites in the main arena, coronary theater and structural heart theater. Abiomed also anticipates panel discussions on the Impella technology throughout the week.

Wednesday, Sept. 22
TCT 19th Annual Cardiovascular Nurse and Technologist Symposium (Part 2) breakout session I,? room 202A,? Washington Convention Center. From 11:10-11:20 a.m. – “Which Hemodynamic Support Device for Which Patient: IABP and Impella,” presented by Brijeshwar Maini, M.D., Pinnacle Health and Vascular Institute.

Thursday, Sept. 23
• Abiomed-sponsored breakfast sessions are held from 7-8 a.m. Part I: “The Case for Hemodynamic Support: Underlying Science and Clinical Evidence,” ?room 140A,? Washington Convention Center, USpella registry update by William O’Neill, M.D., University of Miami. “The Science of Hemodynamic Support,” John Lasala, M.D., Ph.D., Washington University School of Medicine, Barnes-Jewish Hospital, St. Louis.

• TCT session “Optimizing Primary PCI for STEMI in the Cath Lab,” room 147AB,? Washington Convention Center. From 11:17–11:27 a.m. – “Hemodynamic Support for Shock: Choosing Between IABP, Impella and Tandem Heart,” presented by Vladimir Dzavik, M.D., University Health Network. From 11:27–11:37 a.m. - “Experiences with Impella in STEMI: The USpella study,” presented by Brijeshwar Maini, M.D., Pinnacle Health and Vascular Institute.

Friday, Sept. 24
Abiomed-sponsored breakfast session 7-8 a.m. – Part ll: “Hemodynamic Support Today and in the Future: A Case-Based Review,”? room 140A,? Washington Convention Center. Opening remarks, Srihari Naidu, M.D., Winthrop University Hospital. Case reviews and panel discussion, Salman Arain, M.D., Tulane University Heart & Vascular Institute; Wissam Gharib, M.D., West Virginia University Cardiology, and Mark Grise, M.D., John Ochsner Heart and Vascular Institute. Future directions of Impella, Brijeshwar Maini, M.D., Pinnacle Health and Vascular Institute.

Saturday, Sept. 25
Abiomed-sponsored breakfast session, 7-8 a.m. – Part III: “Impella Case Review of Award-Winning Fellows’ Presentations,”? room 143B,? Washington Convention Center. Opening remarks and “Hospital Impella Experience,” Theodore Schreiber, M.D., DMC Cardiovascular Institute/Harper University Hospital. “Award-Winning Impella Cases,” Schreiber, Neeraj Jolly, M.D., University of Chicago Medical Center and Roxana Mehran, M.D., Mount Sinai Medical Center.

For more information: www.abiomed.com

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init